TYOYY vs HQY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TYOYY · Taiyo Yuden (ADR)$10.68 ▲ 0.75%
HQY · HealthEquity$103.63 ▲ 0.16%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TYOYY +70.0%
- HQY +3.8%
Head to head
| Metric | TYOYY | HQY |
|---|---|---|
| Price | $10.68 | $103.63 |
| Change today | ▲ 0.75% | ▲ 0.16% |
| Market cap | $8.57B | $8.57B |
| Return, 3 months | -29.6% | -3.0% |
| Return, year to date | +91.5% | +13.1% |
| Return, 1 year | +70.0% | +10.6% |
| P/E (TTM) | 53.4 | 37.4 |
| P/B | 2.3 | 4.3 |
| P/E percentile vs own 5y | – | 48th |
| Dividend yield | 1.33% | – |
| Revenue growth (YoY, latest qtr) | – | +7.6% |
| Net profit growth (YoY) | – | +9.7% |
| Gross margin | – | 71.2% |
| Operating margin | – | 26.1% |
| Net margin | – | 17.4% |
| Return on equity | – | 11.4% |
| Analyst target vs. price | – | +16.9% |
| Analyst buy share | – | 100% |
| RSI (14) | 28 | 59 |
| 30-day volatility | 78.3% | 33.8% |
| Max drawdown, 1 year | -69.1% | -30.6% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TYOYY is the largest of the group by market value.
- TYOYY has returned the most over the past year.
- HQY carries the lowest trailing P/E.
- HQY has been the calmest stock over the last 30 days.